Obesity drugs are medications developed to help individuals lose weight and manage obesity-related health conditions. These treatments work through various mechanisms, including appetite suppression, metabolic enhancement, and reduced nutrient absorption. The market for obesity drugs has expanded rapidly due to rising global obesity rates and increased focus on chronic disease prevention. Investors closely watch this sector for advancements in drug efficacy, safety profiles, and regulatory approvals.